These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24345265)

  • 21. Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.
    D'Souza MS; Markou A
    Neuropharmacology; 2012 Mar; 62(3):1564-73. PubMed ID: 21288470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders.
    Mihailescu S; Drucker-Colín R
    Arch Med Res; 2000; 31(2):131-44. PubMed ID: 10880717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia.
    Hambsch B; Keyworth H; Lind J; Otte DM; Racz I; Kitchen I; Bailey A; Zimmer A
    Br J Pharmacol; 2014 Apr; 171(7):1758-71. PubMed ID: 24417347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Nicotine in Schizophrenia.
    Featherstone RE; Siegel SJ
    Int Rev Neurobiol; 2015; 124():23-78. PubMed ID: 26472525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits.
    Philpot RM
    Neurochem Res; 2015 Oct; 40(10):2018-31. PubMed ID: 25652578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.
    Sacco KA; Termine A; Seyal A; Dudas MM; Vessicchio JC; Krishnan-Sarin S; Jatlow PI; Wexler BE; George TP
    Arch Gen Psychiatry; 2005 Jun; 62(6):649-59. PubMed ID: 15939842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study.
    Winterer G; Gallinat J; Brinkmeyer J; Musso F; Kornhuber J; Thuerauf N; Rujescu D; Favis R; Sun Y; Franc MA; Ouwerkerk-Mahadevan S; Janssens L; Timmers M; Streffer JR
    Neuropharmacology; 2013 Jan; 64():197-204. PubMed ID: 22766391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
    Uchiumi O; Kasahara Y; Fukui A; Hall FS; Uhl GR; Sora I
    Neuropharmacology; 2013 Jan; 64():348-56. PubMed ID: 22809709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.
    Cannon CE; Puri V; Vivian JA; Egbertson MS; Eddins D; Uslaner JM
    Neuropharmacology; 2013 Jan; 64():191-6. PubMed ID: 22659472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
    McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.
    Wishka DG; Walker DP; Yates KM; Reitz SC; Jia S; Myers JK; Olson KL; Jacobsen EJ; Wolfe ML; Groppi VE; Hanchar AJ; Thornburgh BA; Cortes-Burgos LA; Wong EH; Staton BA; Raub TJ; Higdon NR; Wall TM; Hurst RS; Walters RR; Hoffmann WE; Hajos M; Franklin S; Carey G; Gold LH; Cook KK; Sands SB; Zhao SX; Soglia JR; Kalgutkar AS; Arneric SP; Rogers BN
    J Med Chem; 2006 Jul; 49(14):4425-36. PubMed ID: 16821801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity and variability of the effects of nicotine on different cortical regions of the brain - therapeutic and toxicological implications.
    Toledano A; Alvarez MI; Toledano-Díaz A
    Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):180-206. PubMed ID: 20528766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition.
    Miyauchi M; Neugebauer NM; Oyamada Y; Meltzer HY
    Behav Brain Res; 2016 Mar; 301():204-12. PubMed ID: 26519556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A review of the effects of nicotine on schizophrenia].
    Bidzan L
    Psychiatr Pol; 2007; 41(5):737-44. PubMed ID: 18421928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine improves performance in an attentional set shifting task in rats.
    Allison C; Shoaib M
    Neuropharmacology; 2013 Jan; 64():314-20. PubMed ID: 22776507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.
    Boggs DL; Surti TS; Esterlis I; Pittman B; Cosgrove K; Sewell RA; Ranganathan M; D'Souza DC
    Schizophr Res; 2018 Apr; 194():62-69. PubMed ID: 28392208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hippocampal changes produced by overexpression of the human CHRNA5/A3/B4 gene cluster may underlie cognitive deficits rescued by nicotine in transgenic mice.
    Molas S; Gener T; Güell J; Martín M; Ballesteros-Yáñez I; Sanchez-Vives MV; Dierssen M
    Acta Neuropathol Commun; 2014 Nov; 2():147. PubMed ID: 25384568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia.
    Karamihalev S; Prickaerts J; van Goethem NP
    Behav Brain Res; 2014 Oct; 272():248-51. PubMed ID: 25036424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.
    Brunzell DH; McIntosh JM; Papke RL
    Ann N Y Acad Sci; 2014 Oct; 1327(1):27-45. PubMed ID: 24730978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.